BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lombardo R, Musumeci T, Carbone C, Pignatello R. Nanotechnologies for intranasal drug delivery: an update of literature. Pharm Dev Technol 2021;26:824-45. [PMID: 34218736 DOI: 10.1080/10837450.2021.1950186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar M, Dogra R, Mandal UK. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 2022;74:103533. [DOI: 10.1016/j.jddst.2022.103533] [Reference Citation Analysis]
2 Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs. CNS Drugs 2022. [PMID: 35759210 DOI: 10.1007/s40263-022-00930-4] [Reference Citation Analysis]
3 Patel V, Patel P, Patel JV, Patel PM. Dendrimer as a versatile platform for biomedical application: A review. Journal of the Indian Chemical Society 2022. [DOI: 10.1016/j.jics.2022.100516] [Reference Citation Analysis]
4 Kutchy NA, Ma R, Liu Y, Buch S, Hu G. Extracellular Vesicle-Mediated Delivery of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles to Mice Brain. Front Pharmacol 2022;13:819516. [DOI: 10.3389/fphar.2022.819516] [Reference Citation Analysis]
5 Zingale E, Bonaccorso A, Carbone C, Musumeci T, Pignatello R. Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications. Pharmaceutics 2022;14:691. [PMID: 35456525 DOI: 10.3390/pharmaceutics14040691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Corsaro R, Lombardo R, Ghelardini C, Di Cesare Mannelli L, Bani D, Bonaccorso A, Pignatello R. Development of Eudragit® Nanoparticles for Intranasal Drug Delivery: Preliminary Technological and Toxicological Evaluation. Applied Sciences 2022;12:2373. [DOI: 10.3390/app12052373] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 García-Fernández A, Sancenón F, Martínez-Máñez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev 2021;177:113953. [PMID: 34474094 DOI: 10.1016/j.addr.2021.113953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]